CEBPD and neoplasm: Particularly, the mRNA level of CEBPD showed a stepwise escalation from non‐tumour urothelium, non‐muscle invasive bladder cancer (NMIBC), to muscle invasive bladder cancer (MIBC) (NMIBC vs. Normal, p < .001; MIBC vs. Normal, p = .048; MIBC vs. NMIBC, p = .006; Figure S2A).